The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; PharmaMar; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; PharmaMar
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
 
Honoraria - Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
Other Relationship - Amgen
 
Other Relationship - Amgen
Efficacy and safety of ABP 798 compared with rituximab: Results from the comparative clinical study in patients with non-Hodgkin’s.
 
Dietger Niederwieser
Honoraria - Cellectis; Novartis
Consulting or Advisory Role - Daiichi Sankyo
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - EUSA Pharma
 
Caroline M. Hamm
Consulting or Advisory Role - Amgen; Janssen Oncology; Jazz Pharmaceuticals; Novartis; Paladin; Pfizer; Teva Innovation Canada
 
Patrick Cobb
No Relationships to Disclose
 
Mindy Mo
Employment - Amgen; AstraZeneca
Stock and Other Ownership Interests - Amgen; AstraZeneca
 
Cecily Forsyth
No Relationships to Disclose
 
Alessandra Tucci
Consulting or Advisory Role - Gentili
Other Relationship - Amgen
 
Vladimir Hanes
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Vincent Delwail
Other Relationship - Amgen
 
Roman Hajek
No Relationships to Disclose
 
David Chien
Employment - Amgen
Stock and Other Ownership Interests - Abbvie; Amgen; Nektar